Indometacin Atb

Indometacin, the active ingredient in Indometacin Atb, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a rectal formulation for rectal use. It is employed to relieve pain, reduce inflammation, and manage symptoms of rheumatic conditions such as rheumatoid arthritis, osteoarthritis, and gout in adult patients, and is commonly prescribed when oral NSAIDs are unsuitable. The rectal route provides localized delivery with systemic effect. It is approved for use throughout the European Union.

GNH USA supplies Indometacin Atb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indometacin is indicated for several inflammatory and painful conditions affecting the musculoskeletal system.

- Rheumatoid arthritis: reduces joint inflammation and pain. - Osteoarthritis: alleviates chronic joint discomfort and swelling. - Gout: diminishes acute gouty arthritis attacks. - Pain relief: provides analgesic effect for moderate to severe pain. - Inflammation reduction: lowers prostaglandin‑mediated inflammation in various tissues.

Indometacin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness: transient episodes of light‑headedness. - Skin rash: mild erythematous eruptions.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Acute renal impairment or failure. - Hepatotoxicity: elevated liver enzymes or hepatitis.

Before prescribing Indometacin, clinicians should evaluate patient‑specific risk factors and monitor for adverse events.

- Assess gastrointestinal risk: review history of ulcers or bleeding. - Monitor renal function: check serum creatinine and electrolytes regularly. - Avoid in patients with known hypersensitivity to NSAIDs. - Use the lowest effective dose: limit duration to the shortest period necessary. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Indometacin can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Lithium: heightened lithium serum concentrations. - Methotrexate: reduced clearance leading to toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in antihypertensive effect and renal function. - Selective serotonin reuptake inhibitors (SSRIs): additive bleeding risk. - Corticosteroids: enhanced gastrointestinal ulcer risk.